NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest NNNN stock research?

Anbio Biotechnology Class A Ordinary Shares (NNNN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NNNN moved +2.57% today.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

What can I research for NNNN on Rallies?
Anbio Biotechnology Class A Ordinary Shares (NNNN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NNNN moved +2.57% today.
Does Rallies show live market data for NNNN?
Rallies combines live market context with ticker research for NNNN, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
NNNN

NNNN